JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 33 No. 6 1091-1098
© 1992 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taillefer, R.
Right arrow Articles by Léveillé, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taillefer, R.
Right arrow Articles by Léveillé, J.

Comparison Between Thallium-201, Technetium-99m-Sestamibi and Technetium-99m-Teboroxime Planar Myocardial Perfusion Imaging in Detection of Coronary Artery Disease

Raymond Taillefer, Raymond Lambert, Richard Essiambre, Denis Carl Phaneuf and Jean Léveillé

From the Department of Nuclear Medicine and Division of Cardiology, Hôpital Hôtel-Dieu de Montréal, Université de Montréal, Montréal, Canada

Correspondence: For reprints contact: Dr. Raymond Taillefer, Département de Médecine Nucléaire, Hôtel-Dieu de Montréal, 3840 St-Urbain St., Montreal, Quebec, H2W 1T8, Canada.

ABSTRACT

Technetium-99m-sestamibi (MIBI) and 99mTc-teboroxime (TEBO) are two new myocardial perfusion imaging agents. The purpose of this prospective study was to compare MIBI and TEBO to 201Tl planar imaging. Eighteen patients with significant coronary artery disease on coronary angiogram were submitted to three treadmill stress tests performed within 3 mo and were imaged with the three radiopharmaceuticals as follows.

1 Tl: 2.2 mCi, immediate and delayed views (4 hr later, 8 min/view).
2 TEBO: 15–20 mCi at stress (1 min/view) and a second injection was repeated 4 hr later at rest (20–25 mCi).
3 MIBI: 15–18 mCi at stress (8 min/view) and 1–4 days later, 15–18 mCi at rest.

Patients achieved similar levels of exercise. A blinded reading was performed by three observers. The left ventricle was divided into three segments/view and ischemic/normal wall ratios were also determined. Segmental comparison showed an agreement in 85% (138/162) of the segments between Tl and TEBO, in 92% (149/162) between Tl and MIBI and in 84% (136/162) between MIBI and TEBO. Abnormal Tl, MIBI and TEBO studies were seen in 16 (89%), 16 (89%) and 15 (83%) patients, respectively, detecting 77, 75 and 65 abnormal segments. Ischemic-to-normal wall ratios were 0.75 ± 0.06, 0.73 ± 0.08 and 0.78 ± 0.08 for Tl, MIBI and TEBO, respectively. In conclusion, although the biologic characteristics of these agents are different, this study showed a good correlation between them in detection of significant coronary artery disease (high pretest likelihood population).




This article has been cited by other articles:


Home page
JNMHome page
E. Verna, L. Ceriani, L. Giovanella, G. Binaghi, and S. Garancini
"False-Positive" Myocardial Perfusion Scintigraphy Findings in Patients with Angiographically Normal Coronary Arteries: Insights from Intravascular Sonography Studies
J. Nucl. Med., December 1, 2000; 41(12): 1935 - 1940.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. D. Miller
The Growing Flood of Technetium-99m Myocardial Perfusion Agents : More Water . . . or More Mud?
Circulation, January 15, 1995; 91(2): 555 - 558.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1992 by the Society of Nuclear Medicine.